HALIFAX, NS, Jan. 31, 2024 /CNW/ – G2S2 Capital Inc. (“G2S2”) announces that its wholly owned subsidiary has acquired an additional 147,000 common shares of Knight Therapeutics Inc. (“Knight”), representing approximately 0.14% of the outstanding common shares of Knight. G2S2’s wholly owned subsidiary, Armco Alberta Inc., acquired the common shares on January 31^st, 2024, through the facilities of the Toronto Stock Exchange at a price of $5.35 per share (the “Acquisition”).

Continue Reading